74 related articles for article (PubMed ID: 12390714)
21. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
22. [Image evaluation of liver metastases].
Matsueda K; Inaba Y; Arai Y
Nihon Geka Gakkai Zasshi; 2003 Oct; 104(10):696-700. PubMed ID: 14579754
[TBL] [Abstract][Full Text] [Related]
23. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions.
Poeckler-Schoeniger C; Koepke J; Gueckel F; Sturm J; Georgi M
Magn Reson Imaging; 1999 Apr; 17(3):383-92. PubMed ID: 10195581
[TBL] [Abstract][Full Text] [Related]
24. MRI contrast agents for evaluating focal hepatic lesions.
Harisinghani MG; Jhaveri KS; Weissleder R; Schima W; Saini S; Hahn PF; Mueller PR
Clin Radiol; 2001 Sep; 56(9):714-25. PubMed ID: 11585393
[TBL] [Abstract][Full Text] [Related]
25. Detection of siderotic nodules in the liver with susceptibility weighted imaging: correlations to serum ferritin, Child-Pugh grade and hyaluronic acid levels.
Tao R; You ZL; Zhang JQ; Dai YM; Zhou DQ; Cai P; Fan Y; Cui JG; Wang J
Chin Med J (Engl); 2012 Sep; 125(17):3110-4. PubMed ID: 22932190
[TBL] [Abstract][Full Text] [Related]
26. [Magnetic resonance tomography: value and limits in gastroenterologic diagnosis].
Laniado M; Duda S; Claussen CD
Bildgebung; 1992 Jun; 59(2):61-7. PubMed ID: 1511212
[TBL] [Abstract][Full Text] [Related]
27. Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions.
Chang JM; Lee JM; Lee MW; Choi JY; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2006 Feb; 41(2):168-74. PubMed ID: 16428988
[TBL] [Abstract][Full Text] [Related]
28. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark DD; Weissleder R; Elizondo G; Hahn PF; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Aug; 168(2):297-301. PubMed ID: 3393649
[TBL] [Abstract][Full Text] [Related]
29. [Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT].
Hirohashi S; Hirohashi R; Uchida H; Kachi K; Ohtomo K; Uchiyama G; Niitsu M; Itai Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):776-83. PubMed ID: 8072868
[TBL] [Abstract][Full Text] [Related]
30. [MRI aspect of hepatic adenomatosis].
Barbier C; Denny P; Becker S; Aiouaz C; Krakowski I; Prenat T
J Radiol; 1997 Dec; 78(12):1281-4. PubMed ID: 9499969
[TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
Weissleder R; Hahn PF; Stark DD; Elizondo G; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Nov; 169(2):399-403. PubMed ID: 3174987
[TBL] [Abstract][Full Text] [Related]
32. Transient hepatic intensity differences: part 2, Those not associated with focal lesions.
Colagrande S; Centi N; Galdiero R; Ragozzino A
AJR Am J Roentgenol; 2007 Jan; 188(1):160-6. PubMed ID: 17179359
[TBL] [Abstract][Full Text] [Related]
33. Hepatic imaging with iron oxide magnetic resonance imaging.
Schultz JF; Kuhn JA; McCarty TM
Oncology (Williston Park); 2000 Jun; 14(6 Suppl 3):29-36. PubMed ID: 10887649
[TBL] [Abstract][Full Text] [Related]
34. Transient hepatic intensity differences: part 1, Those associated with focal lesions.
Colagrande S; Centi N; Galdiero R; Ragozzino A
AJR Am J Roentgenol; 2007 Jan; 188(1):154-9. PubMed ID: 17179358
[TBL] [Abstract][Full Text] [Related]
35. Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide.
Balci NC; Sirvanci M; Duran C; Akinci A
Clin Imaging; 2002; 26(1):35-8. PubMed ID: 11814751
[TBL] [Abstract][Full Text] [Related]
36. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Wang YX
Quant Imaging Med Surg; 2011 Dec; 1(1):35-40. PubMed ID: 23256052
[TBL] [Abstract][Full Text] [Related]
37. Superparamagnetic iron oxide imaging of focal liver disease.
Taylor PM; Hawnaur JM; Hutchinson CE
Clin Radiol; 1995 Apr; 50(4):215-9. PubMed ID: 7729116
[TBL] [Abstract][Full Text] [Related]
38. Enhanced tumor detection in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent (NSR 0430).
Bachmann R; Kreft B; Dombrowski F; Block W; Oksendal A; Schild H
J Magn Reson Imaging; 1999 Feb; 9(2):251-6. PubMed ID: 10077021
[TBL] [Abstract][Full Text] [Related]
39. Superparamagnetic iron oxide-enhanced magnetic resonance imaging in a case of spleen hamartoma.
Bulakci M; Yilmaz E; Yahyayev A; Bulakci BB; Yekeler E
Med Princ Pract; 2013; 22(3):301-3. PubMed ID: 23107785
[TBL] [Abstract][Full Text] [Related]
40. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging.
Tsang YM; Stark DD; Chen MC; Weissleder R; Wittenberg J; Ferrucci JT
Radiology; 1988 Apr; 167(1):21-4. PubMed ID: 3347724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
